FDA approved Protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught)
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
On Apr. 12, 1985, the Haemophilus influenzae type b (Hib) polysaccharide vaccines (b-CAPSA 1 by Praxis Biologics, Hib-VAX…
In 1981, the U.S. Centers for Disease Control and Prevention (CDC) began collecting reports of influenza outbreaks from…
On Feb. 5, 1976, in an army recruit at Fort Dix said he felt tired and weak. He…
In 1976, the U.S. Centers for Disease Control and Prevention (CDC) was involved in a national immunization program…
In 1970, influenza H3N2 viruses were first identified in swine during an influenza surveillance study in Taiwan. This…
The 1968 pandemic, also known as the Hong Kong flu, was caused by an influenza A (H3N2) virus…
In 1968, a pandemic was caused by an influenza A (H3N2) virus comprised of two genes from an…
In 1967, Dr. H.G. Pereira and colleagues propose a relationship between human and avian flu viruses after a…
In 1966, the FDA licensed amantadine (marketed as Symmetrel) to Du Pont , a new antiviral medication, as…
In 1962, the U.S. Centers for Disease Control and Prevention (CDC) launched the 122 Cities Mortality Reporting System…
In 1961, influenza virus was first isolated from wild birds in South Africa, from common terns (Sterna hirundo),…
In 1960, the U.S. Surgeon General, in response to substantial morbidity and mortality during the 1957ï¾–58 pandemic, recommends…
In Feb. 1957, a new influenza A (H2N2) virus emerged in East Asia, triggering a pandemic (‘Asian Flu’)….
In 1957, a new H2N2 flu virus emergedï¾ to trigger a pandemic. There were about 1.1 million deaths globally,…
In 1957, the ‘Asian flu’ influenza pandemic emerged, resulting in the CDC setting up an influenza surveillance unit,…
In 1956, the CDC’s Influenza Branch in Atlanta was designated a World Health Organization (WHO) Collaborating Centre for…
Since 1952, global influenza surveillance has been conducted through WHO’s Global Influenza Surveillance and Response System (GISRS). The…
In 1952, the Global Influenza Surveillance and Response System (GISRS) was created by World Health Organization (WHO) to…
In 1948, the World Health Organization (WHO) Influenza Centre was established at the National Institute for Medical Research…
In 1948, Dr. Isabel M. Morgan of Johns Hopkins University demonstrated definitively that chemically inactivated poliovirus derived from…
In 1947, during the seasonal flu epidemic of 1947, investigators determined that changes in the antigenic composition of…
In 1947, Dr. Jonas Salk was recruited from the University of Michigan by Dr. William S. McEllroy, dean…
In late 1946, an outbreak of influenza occurred in Japan and Korea in American troops. It spread in…
In 1945, the inactivated influenza vaccine was first licensed in the U.S. The first vaccine was an inactivated,…
In 1944, the use of cell cultures for virus growth was discovered. This allowed viruses to be cultured…
In 1942, influenza A/B vaccine was introduced to the Armed Forces Epidemiological Board. The vaccine was effective against…
In 1942, Dr. Jonas Salk arrived at the University of Michigan School of Public Health. Techniques earned there…
In 1940, Thomas Francis, Jr, MD isolated the influenza B virus from a child in 1940. Francis helped…
In 1939, Margaret Pittman showed that sulfapyradine was effective against nontype-specific Haemophilus influenzae. Pittman discovered that there are…